The National Institutes of Health (NIH) is a leading biomedical research facility in the United States, operating under the Department of Health and Human Services. Established in 1887 and based in Bethesda, Maryland, NIH is the primary agency responsible for biomedical and health-related research in the country. It comprises 27 separate institutes and centers, each focusing on different disciplines within biomedical science. NIH conducts its own scientific research through the Intramural Research Program and provides significant funding for research at external institutions via the Extramural Research Program. With a workforce that includes 1,200 principal investigators and over 4,000 postdoctoral fellows, NIH has been instrumental in major medical breakthroughs, such as the development of vaccines for hepatitis and human papillomavirus, as well as the discovery of treatments for various health conditions. As the world's largest source of medical research funding, NIH continues to advance scientific knowledge and contribute to public health improvements.

General Catalyst is a venture capital firm established in 2000 and based in San Francisco, California. The firm specializes in early-stage and growth equity investments across various sectors, including consumer, enterprise, fintech, cryptocurrency, and health assurance. By fostering an environment conducive to growth, General Catalyst aims to accelerate the development of innovative ideas and companies. The firm provides mentorship and connects clients with experienced professionals to enhance their potential for success. As a Registered Investment Adviser, General Catalyst has managed a total of eight venture capital funds, accumulating approximately $3.75 billion in capital commitments.

Alumni Ventures Group, LLC is a venture capital firm based in Manchester, New Hampshire, founded in 2013. The firm specializes in seed and early-stage investments, as well as late-stage pre-IPO opportunities, with a flexible approach that is sector and geographic agnostic. Alumni Ventures aims to provide high-quality, diversified venture portfolios to individual investors, particularly accredited alumni from top entrepreneurial schools, who may not have had access to venture capital previously. The firm focuses on backing companies that have an alumni connection and are led by established institutional investors with expertise in their respective fields. Additionally, Alumni Ventures offers focused funds that enable accredited investors to access a diverse portfolio of investments across various types, sectors, stages, and geographies.

MassChallenge is a global nonprofit startup accelerator headquartered in Boston, Massachusetts, founded in 2009. It supports early-stage entrepreneurs from various industries, including technology, healthcare, and finance, by providing mentorship, resources, and networking opportunities. With locations in countries such as Israel, Mexico, Switzerland, and Texas, MassChallenge operates a non-equity model, allowing startups to retain full ownership while benefiting from expert guidance and connections. The accelerator conducts various programs tailored to specific sectors, such as MassChallenge HealthTech and MassChallenge FinTech, which facilitate partnerships between startups and established enterprises to drive innovation and market growth. Through its extensive global network, MassChallenge aims to strengthen the innovation ecosystem and empower high-potential startups to create meaningful impact.

RA Capital Management is a Boston-based investment advisor founded in 2004, specializing in the life sciences and healthcare sectors. The firm focuses on early-stage companies developing innovative technologies, products, and services in drug development, medical devices, diagnostics, and research tools. With a team of professionals trained in biology, chemistry, and medicine, RA Capital Management leverages its extensive industry and business development experience to identify and invest in promising healthcare ventures. As a Registered Investment Adviser, the firm employs a strategic approach that includes both venture capital investments and a hedge fund strategy, targeting opportunities primarily in the United States and Europe.

The National Science Foundation (NSF) is an independent federal agency established in 1950 and based in Alexandria, Virginia. It is dedicated to supporting research and education in science and engineering across a wide range of disciplines. The NSF provides significant non-dilutive funding, up to $1.5 million, to startups and small businesses through its America's Seed Fund initiative, which is part of the Small Business Innovation Research (SBIR) program mandated by Congress. With an operating budget of approximately $7.8 billion, the NSF is committed to advancing fundamental research and education, thus fostering innovation and technological development in the United States.

SOSV is a global venture capital firm based in Princeton, New Jersey, founded in 1995. It specializes in early-stage investments, focusing on deep technology innovations that address human and planetary health. The firm operates startup development programs, notably HAX and IndieBio, which provide resources, facilities, and lab equipment to accelerate the growth of promising startups. SOSV supports companies from their inception through various funding stages, including seed and series A rounds, while offering ongoing assistance to help them scale and attract additional investors. By concentrating on revolutionary technologies and cross-border markets, particularly in Asia, SOSV aims to foster significant advancements that benefit humanity and the environment.

Founded in 2009 by Marc Andreessen and Ben Horowitz, Andreessen Horowitz is a venture capital firm based in Menlo Park, California. The firm specializes in incubating and investing in startups across various stages, from seed to late-stage funding. It primarily focuses on sectors such as technology, including software, cloud computing, enterprise software, and consumer Internet. Additionally, it invests in emerging fields like artificial intelligence, fintech, and healthcare, specifically targeting companies at the intersection of technology and life sciences, such as digital therapeutics and computational medicine. Andreessen Horowitz is committed to fostering innovation and supporting companies that contribute to American dynamism, while strategically avoiding investments in areas like clean energy, transportation, and consumer retail.

ARCH Venture Partners, founded in 1986 and based in Chicago, Illinois, is a venture capital firm that specializes in investing in early-stage technology companies, particularly in the life sciences sector. The firm focuses on innovations that emerge from academic research institutions and national laboratories, making it a recognized leader in the commercialization of such technologies. ARCH invests conservatively in seed rounds to mitigate risk and subsequently leads or co-leads further financing rounds, aiming for a seat on the Board of Directors. Its investment strategy encompasses a wide range of sectors, including biotechnology, pharmaceuticals, advanced materials, and clean technology, among others. ARCH primarily invests in the United States while also targeting opportunities in countries like Canada, Ireland, South Korea, China, and Japan. The firm has raised over $3 billion across ten venture funds and has supported more than 150 companies in their early capital rounds.

New Enterprise Associates, Inc. is a private equity and venture capital firm founded in 1977 and headquartered in Menlo Park, California, with additional offices in India and China. The firm specializes in investing across various stages of business development, from seed funding to public offerings, with a strong emphasis on the technology and healthcare sectors. Its investment strategy encompasses a wide range of industries, including information technology, consumer internet, financial technology, software, healthcare services, life sciences, biopharmaceuticals, and energy technology. New Enterprise Associates actively engages with entrepreneurs to support the growth of their companies, making investments between $0.05 million and $20 million. The firm has a global investment focus, particularly in regions such as Asia, Brazil, and the United States.

GV Investment Managers is a private equity firm founded in 2000 and based in Stamford, Connecticut. The firm specializes in impact investing, private equity, and portfolio management services. It focuses on sectors such as life sciences, consumer products, enterprise solutions, cryptocurrency, climate technology, and frontier innovations. With Alphabet as its sole limited partner, GV Investment Managers primarily targets investments in North America and Europe. The firm collaborates with operating partners who assist startups in areas such as design, diversity and inclusion, talent acquisition, and engineering, while also facilitating connections with Google for technological support and expertise.

OrbiMed is a healthcare-focused investment firm based in New York City, established in 1989. The firm specializes in providing a range of financing solutions, including bridge loans, senior debt, and structured debt capital for both commercial-stage public and private healthcare companies. OrbiMed invests across various sectors within the healthcare industry, such as pharmaceuticals, life sciences, digital health, medical devices, biopharmaceuticals, diagnostics, healthcare technology, and biotechnology. With approximately $5 billion in assets under management, OrbiMed aims to support a spectrum of healthcare companies, from early-stage ventures to established multinational corporations.

Khosla Ventures, founded in 2004 and headquartered in Menlo Park, California, is a venture capital firm that provides strategic advice, capital, and support to bold entrepreneurs across various sectors. The firm focuses on early-stage investments in areas such as artificial intelligence, climate technology, sustainability, enterprise solutions, consumer products, fintech, digital health, medical technology, and therapeutics. Khosla Ventures is particularly interested in innovative solutions that address significant socio-economic challenges and enhance productivity, especially for low-income populations and small businesses in emerging markets. The firm embraces experimentation and is open to investing in unconventional and high-risk ventures, often acting as the sole investor in groundbreaking projects. With a commitment to fostering impactful entrepreneurship, Khosla Ventures seeks to create value through technological advancements and creative business models, with a special emphasis on markets in South Asia.

Antler is a global early-stage venture capital firm focused on investing in technology companies and incubating startups across various sectors. The firm aims to build the defining companies of tomorrow by identifying and supporting exceptional entrepreneurs. Antler provides a comprehensive ecosystem that includes a global network of co-founders, access to talent, expert advisors, and expansion support, along with the necessary capital to help startups grow and succeed.

Qiming Venture Partners is a prominent venture capital firm based in Shanghai, China, founded in 2006. With additional offices in Beijing, Suzhou, Hong Kong, and Singapore, the firm focuses on early to growth-stage investments across various sectors, including healthcare, information technology, consumer goods, mobile internet, artificial intelligence, and clean technology. Qiming Venture Partners has a strong track record, having invested in over 530 innovative companies, with more than 200 achieving successful exits through public offerings or mergers and acquisitions. The firm is recognized for its deep technical expertise and hands-on operational support, making it a preferred partner for CEOs and startups seeking to scale their operations. Its partners are often sought after as board members, reflecting their status as respected business leaders and thought leaders in the venture capital landscape.

Echo Health Ventures is a venture capital firm established in 2016, with offices in Durham, Portland, and Seattle. The firm specializes in investing in healthcare companies, aiming to accelerate their innovations for national scalability. Echo Health Ventures takes a stage-agnostic approach to investing, seeking to build deep, high-value relationships with portfolio companies beyond just providing capital. This commitment to fostering collaboration helps drive the growth and success of the healthcare startups in which they invest.

F-Prime Capital is a venture capital firm established in 1969 and headquartered in Cambridge, Massachusetts, with additional offices in San Francisco and London. It is part of the Fidelity Investments family, which has a long history of supporting entrepreneurs. F-Prime Capital focuses its investments on companies in North America and Europe, specializing in sectors such as healthcare, life sciences, therapeutics, fashion, medtech, health information technology and services, and technology. The firm emphasizes a hands-on approach, leveraging its deep industry expertise and extensive relationships to assist entrepreneurs in building significant companies. F-Prime Capital operates without the pressures of external fundraising, allowing it to concentrate on identifying and nurturing promising ventures.

StartUp Health is investing in a global army of Health Transformers to achieve health moonshots. StartUp Health is on a 30-year mission to collaborate with entrepreneurs to improve the health and wellbeing of everyone in the world. Since 2011, StartUp Health has been investing in a global army of entrepreneurs -- called Health Transformers -- to achieve health moonshots: Access to Care, Cost to Zero, Cure Disease, End to Cancer, Women’s Health, Children’s Health, Nutrition and Fitness, Brain Health, Mental Health and Happiness, Addiction, Longevity, and Pandemic Response. StartUp Health has the world’s largest health innovation portfolio with more than 330 companies across six continents and 26 countries and is backed by leading investors including Advocate Aurora Health, Chiesi, Steve Case, Mark Cuban, Esther Dyson, Brad Feld, GuideWell, Jason Finger, Jerry Levin, Kaiser Permanente, Masimo, Novartis, Otsuka, and Ping An.

Gaingels is a venture investment syndicate founded in 2014 and based in Burlington, Vermont, dedicated to supporting the LGBT+ community and its allies. The organization invests in companies led by LGBT+ founders and executives at all stages of development, as well as in established firms committed to enhancing their diversity and inclusivity. With a global portfolio comprising over 130 companies and $70 million in investment capital deployed, Gaingels plays a vital role in fostering an inclusive business environment. Additionally, the Gaingels network actively assists its portfolio companies in identifying and recruiting diverse talent for their leadership teams, while cultivating a vibrant community of industry leaders, investors, and entrepreneurs committed to driving positive social change through business initiatives.

City Light Capital is a venture capital firm established in 2004 and located in New York, New York. The firm specializes in early-stage investments in impactful companies across various sectors, including education, safety and care, environmental solutions, technology, digital health, climate, food, wellness, energy, agriculture, and the internet of things. City Light Capital partners with experienced teams to develop category-defining solutions that promote positive social and environmental outcomes. As a pioneer in impact investing, the firm has successfully identified and scaled businesses that not only generate revenue but also contribute to better lives at scale.

Frist Cressey Ventures, LLC is a venture capital firm established in 2015 and headquartered in Nashville, Tennessee. The firm specializes in early and growth stage investments, primarily focusing on the healthcare sector. It aims to accelerate the development of high-potential healthcare enterprises by forming value-added partnerships. Frist Cressey Ventures invests in technology and service businesses that offer innovative solutions to enhance quality of care, system integration, patient outcomes, and overall population health. By collaborating with like-minded entrepreneurs who share similar core values, the firm is dedicated to improving the healthcare landscape.

BoxGroup Services, LLC is a venture capital firm based in New York City, founded in 2009. It specializes in early-stage investments, primarily focusing on pre-seed, seed, and early Series A rounds. The firm targets a variety of sectors, including disruptive technology, healthcare, biotech, food, software as a service, e-commerce, and fintech. BoxGroup typically invests between $50,000 and $500,000 in each company, emphasizing a conviction in the founding team and their vision to create category-defining businesses. Although it primarily invests in New York City, Silicon Valley, and Los Angeles, the firm is open to opportunities globally. Notably, BoxGroup does not take board seats or ownership stakes in the companies it supports.

Exact Sciences Corporation is a molecular diagnostics company based in Madison, Wisconsin, specializing in cancer screening and diagnostic tests. The company is best known for Cologuard, a non-invasive stool-based DNA test designed to detect colorectal cancer and pre-cancer, which is endorsed by leading cancer screening guidelines. Additionally, Exact Sciences offers Oncotype DX, a suite of gene expression tests that assess the recurrence risk and treatment benefits for breast and colon cancers, as well as the Oncotype DX AR-V7 Nucleus Detect test for advanced stage prostate cancer. Exact Sciences is committed to advancing its technology through research and development, focusing on enhancing the performance of Cologuard and exploring blood or fluid-based tests. The company holds exclusive intellectual property for its screening technology and has established partnerships with organizations such as the Mayo Foundation for Medical Education and Research.

Polaris Partners is a multibillion-dollar investment firm founded in 1996 and headquartered in Boston, Massachusetts, with an additional office in San Francisco. The firm specializes in investing in healthcare and biotechnology companies, focusing on various aspects of the sector. Its healthcare portfolio includes companies that develop innovative care delivery models, such as digital health solutions, consumer-centric services, patient-provider interactions, as well as data science and analytics. In the biotechnology realm, Polaris targets life sciences firms engaged in research and development of therapeutics, genomic technologies, and molecular platforms. With over 20 years of experience, Polaris Partners collaborates with repeat entrepreneurs and innovators, supporting ventures from their inception through to profitable growth.

Robin Hood Ventures is a group of angel investors, focused on early-stage, high-growth companies in the Greater Philadelphia region. We help entrepreneurs build great companies, providing capital, mentoring, expertise and connections to help companies reach their potential. Robin Hood generally invests $250k to $500k, and collaborates with angels, institutions and VCs in our network. We invest as a single entity in businesses we know and understand, in a way that gets deals done. Since 1999, we have invested in over 45 companies in industries including software, medical devices, biotech, internet and financial technology.

Casdin Capital is a New York-based investment firm established in 2012, specializing in fundamental research within the life sciences and healthcare sectors. The firm focuses on a range of investments, from early-stage to late-stage private opportunities, and is particularly interested in areas such as oncology, digital health, and agtech. As a Registered Investment Adviser, Casdin Capital employs a long-short equity strategy to manage its portfolio. Founded by Eli Casdin, the firm has built a reputation for its analytical approach to investing in innovative healthcare solutions, aiming to capitalize on advancements in the industry. As of October 2020, Casdin Capital managed approximately $2.2 billion in assets.

Forbion Capital Partners is a Netherlands-based venture capital firm focused on investing in life sciences companies in drug development as well as MedTech companies addressing high medical needs. Forbion's investment team of nine investment professionals has built an impressive performance track record since the late nineties with successful investments in Rhein Biotech, Crucell, Neutec, Glycart, Borean, Impella, Alantos, Acorda, Fovea and PanGenetics. Current assets under management exceed €400m ($500m), split between three active funds. Finally, Forbion co-manages BioGeneration Ventures, an early stage fund focused on academic spin-outs and seed investments in the Netherlands.

IndieBio, founded in 2014 and based in San Francisco, is the world’s first accelerator dedicated to startups that leverage biology to address significant global challenges. As part of SOSV, a global venture capital firm, IndieBio focuses on nurturing seed-stage and early-stage companies across various sectors, including healthcare, life sciences, biotechnology, and consumer products. The accelerator provides funding and support to innovative ventures aiming to create impactful solutions in areas such as pharmaceuticals, oncology, and advanced manufacturing. By fostering emerging technologies and biological applications, IndieBio plays a crucial role in advancing the next generation of startups that seek to make a positive difference in society.

MassDevelopment is a provider of financing and real estate solutions that support companies and nonprofits, increase housing, eliminate blight, and drive economic growth across Massachusetts. MassDevelopment is dedicated to stimulating business, driving economic growth, and assisting communities across Massachusetts to thrive. MassDevelopment prioritizes low-cost and creative financing options for a variety of organizations, as well as sustainable redevelopment of surplus properties, the transformation of the Commonwealth's Gateway Cities, and promotion of the Massachusetts manufacturing and defense sectors.

Maverick Ventures is a venture capital firm based in San Francisco, California, founded in 2015. As the venture arm of Maverick Capital, it specializes in providing growth capital primarily in the healthcare, technology, and consumer sectors. In healthcare, the firm focuses on software and services, medical devices, tools and diagnostics, and biotechnology and pharmaceuticals. In the technology and consumer sectors, Maverick Ventures emphasizes investments in online, mobile, and offline-first companies. With a team that combines over 30 years of early-stage investment experience, Maverick Ventures has funded more than 100 companies and actively engages with entrepreneurs from seed funding through to maturation, often leading investment rounds and participating on boards to help build successful enterprises.

Oak HC/FT is a venture and growth equity investment firm specializing in healthcare information services and financial technology. The firm aims to transform these sectors by offering entrepreneurs and companies strategic guidance, board-level involvement, and connections to a broad network of industry leaders. Oak HC/FT has a strong track record, with numerous successful realizations and several companies in its portfolio reaching valuations over $1 billion. The firm is part of Oak Investment Partners and is committed to developing sector-specific funds to foster the growth of innovative businesses in healthcare and financial services.

Town Hall Ventures is a venture capital investment firm based in New York, established in 2018. It focuses on transforming the U.S. healthcare market, particularly for underserved populations and those with higher health needs. The firm collaborates closely with visionary entrepreneurs aiming to enhance care delivery and improve health outcomes through innovative technology solutions. By investing in healthcare technology companies across the United States, Town Hall Ventures seeks to support bold entrepreneurs committed to making significant changes in the healthcare system and positively impacting millions of lives.

Google for Startups is an initiative designed to support and empower startups globally. Established in 2011 and based in San Francisco, the program offers access to Google's products, resources, and best practices through a vast network of partners and six dedicated Google for Startups Campuses located in major cities such as London, Tel Aviv, and São Paulo. Its mission is to foster entrepreneurial success and create a positive impact on the future. By collaborating with over fifty leading startup organizations, Google for Startups enhances local tech ecosystems and supports startups across more than 135 countries. The program provides financial assistance, exclusive programming, and mentorship opportunities. The Google for Startups Campuses serve as collaborative spaces where startup founders can engage with their peers, access educational resources, and receive training from both Google and local experts. These Campuses offer free workspaces, events, and a vibrant community, enabling entrepreneurs to thrive in their respective industries.

Perceptive Advisors LLC is an investment management firm established in 1999, with headquarters in New York City and an additional office in Boston. The firm specializes in supporting the life sciences sector, investing primarily in biotechnology, pharmaceuticals, medical devices, diagnostics, and healthcare services. Perceptive Advisors engages in venture capital and incubation, making equity investments ranging from $10 million to $200 million in both private and public companies. It manages client-focused equity portfolios and employs a long/short equity strategy as part of its hedging techniques. Additionally, the firm conducts in-house research and utilizes technical analysis to inform its investment decisions. Perceptive Advisors also provides customized debt financing solutions through its Perceptive Credit Opportunities Fund, catering to the evolving needs of healthcare companies.

CVS Health is a comprehensive healthcare company that integrates health insurance, pharmacy services, and various healthcare solutions. The company operates over 9,000 retail pharmacies across the United States, providing prescription drug coverage and a range of well-being services. Its significant subsidiaries include CVS Pharmacy, Aetna, and CVS Caremark, the latter being a prominent pharmacy benefit manager that processes approximately 2 billion claims annually. Through its health insurance segment, CVS Health serves around 26 million medical members, enhancing access to affordable healthcare. The recent acquisition of Oak Street adds primary care services, creating potential synergies with its existing operations and further solidifying CVS Health's position in the healthcare industry.

Optum Ventures provides capital and strategic guidance to startup companies solving health care's pressing challenges. It is the venture capital investment arm of Optum that invests in digital health companies that use data and insights to help improve consumers' access to health care services and how care is delivered and paid for, and that makes the health care system more reliable and easier to navigate.

Innovate U.K. is a NPO that offers funding services to support science and technology innovations. The organization offers services and information on births, deaths, marriages, business, self-employed, childcare, parenting, citizenship, law, disabled persons, transportation, education, environment, housing, money, tax, travel, immigration, and jobs. Innovate U.K. is based in Swindon.

Enhanced Capital Partners, established in 1999 and headquartered in New York City, is a national investment firm focused on providing tailored investment solutions to small and mid-size companies. The firm specializes in various sectors, including small businesses, renewable energy projects, historic real estate rehabilitation, and affordable housing, leveraging federal and state incentive programs. Enhanced Capital employs a versatile approach to investment, offering equity and debt financing options such as tax credit lending and impact lending, aimed at maximizing growth potential for businesses in the lower middle market. With over $400 million under management, the firm is committed to supporting the expansion and development of enterprises positioned for rapid growth.

Ally Bridge Group is a healthcare-focused private investment group founded in 2013, with operations in Hong Kong and the United States. The firm specializes in venture and growth capital, buyout, and hedge fund investing, primarily targeting life sciences companies and innovative medical technologies. With a commitment to bridging the gap between groundbreaking healthcare innovations and global markets, Ally Bridge Group invests in both private and public equity across various sectors, including medical devices and biopharmaceuticals. By leveraging its extensive expertise and network, the firm aims to support the development and growth of its portfolio companies, focusing on transformative solutions that address significant unmet medical needs.

Deerfield Management is a New York-based healthcare company founded in 1994 that operates across investment, information, and philanthropy. As a registered investment adviser, it focuses on providing a robust healthcare ecosystem through various investment strategies. The firm engages in both private and public investments, targeting companies within the life sciences, medical device, diagnostic, digital health, and health services sectors. Deerfield's commitment extends beyond financial support, as it also emphasizes the importance of information and philanthropy in enhancing healthcare outcomes.

UnitedHealthcare, an operating division of UnitedHealth Group, is the largest health carrier in the United States, dedicated to enhancing the healthcare system. The company serves approximately 70 million Americans through its extensive network, which includes over 739,000 healthcare professionals and 5,620 hospitals. UnitedHealthcare focuses on improving the quality and effectiveness of healthcare, expanding access to health benefits, and developing affordable products and services. Its commitment to innovation is evident in its investment of nearly $3 billion in research, technology, and process improvements over the past five years, aimed at transforming the delivery of care. Additionally, UnitedHealthcare Medicare Solutions offers tailored insurance plans for Medicare beneficiaries, addressing the specific healthcare needs of seniors and certain younger individuals with disabilities. Through these efforts, UnitedHealthcare strives to make healthcare more accessible and easier to navigate for all.

Venrock is a venture capital investment firm established in 1969, with its headquarters in Palo Alto, California, and additional offices in New York. The firm specializes in investing in both technology and healthcare sectors, targeting companies within the United States. Venrock employs a rigorous approach that combines venture expertise and data analysis to support the growth of its portfolio companies. Its investment scope includes a diverse range of industries such as biotechnology, consumer products, cybersecurity, defense and aerospace, financial technology, software-as-a-service, and artificial intelligence. By focusing on both publicly-held and privately-held companies, Venrock aims to foster innovation and drive success in the sectors it invests in.

Flare Capital Partners is a venture capital firm founded in 2015 and headquartered in Boston, Massachusetts, with an additional office in Rowayton, Connecticut. The firm specializes in growth equity and early-stage investments, focusing primarily on healthcare technology. Flare Capital Partners targets a variety of sectors within healthcare, including medical devices, biopharmaceuticals, diagnostics, predictive medicine, and digital health solutions. The firm seeks to support transformational technologies and services that promote value-based healthcare, leveraging advancements in mobile technology, big data, and analytics. By investing in innovative healthcare technology companies across the United States, Flare Capital Partners aims to drive advancements that improve patient outcomes and enhance healthcare delivery.

First Round Capital is a venture capital firm based in San Francisco, California, founded in 2004. Specializing in seed-stage investments, it focuses on early-stage technology companies across various sectors, including enterprise, fintech, healthcare, consumer, hardware, artificial intelligence, and web3. First Round Capital aims to support entrepreneurs by providing not only capital but also a range of tailored services and resources designed to foster growth. The firm typically invests around $500,000 as initial funding, often serving as a company’s first outside capital. It actively engages with portfolio companies to enhance their development. With a commitment to community, First Round Capital has established a network that has collectively raised over $2.5 billion in follow-on capital, demonstrating a strong track record of facilitating growth among its investments.

LRVHealth is a venture capital firm founded in 2000 and based in Boston, Massachusetts, with additional offices in Marlborough and Amherst. The firm focuses on investing in early-stage and growth-stage companies, particularly in the healthcare sector. LRVHealth specializes in technology-driven businesses, including software, digital health solutions, medical devices, diagnostics, and healthcare technology services. It seeks to provide capital ranging from $0.5 million to $5 million and typically prefers to co-invest while aiming for exits through trade sales. LRVHealth's network includes leading provider, payer, and vendor organizations, which enhances its ability to identify and support innovative solutions to pressing healthcare challenges. The firm's investments are primarily concentrated in the United States, particularly in Massachusetts.

MedTech Innovator is the industry’s nonprofit global competition and accelerator for medical device, digital health and diagnostic companies. Our mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. MedTech Innovator annually features 100 companies that address one or more of the transformative themes identified in an annual survey of leading manufacturers and providers.

Torch Capital is a New York-based venture capital firm founded in 2018, specializing in early-stage investments in consumer technology companies. The firm focuses on supporting visionary founders who leverage technology to transform the way consumers and businesses operate. By concentrating on the essential infrastructure that underpins these advancements, Torch Capital aims to foster innovation and drive growth within the consumer technology sector.

Alexandria Venture Investments, LLC is a venture capital firm established in 1996 and located in Pasadena, California. As a subsidiary of Alexandria Real Estate Equities, the firm specializes in seed, early-stage, and growth capital investments primarily within the healthcare sector. Its focus areas include biopharma, diagnostics, life sciences, research tools, agrifood technology, and technology. By leveraging its extensive industry expertise and a robust network of relationships with leading investors and scientific advisors, Alexandria Venture Investments aims to support innovative companies that are developing breakthrough technologies and therapies to enhance human health.

Liquid 2 Ventures is a venture capital firm based in San Francisco, California, that specializes in seed-stage investments in technology startups. Founded in 2015 by Joe Montana, Mike Miller, and Michael Ma, the firm focuses on identifying and supporting early-stage companies with high growth potential in the tech sector. By providing both financial backing and strategic guidance, Liquid 2 Ventures aims to foster innovation and help emerging businesses navigate their initial stages of development.

Collaborative Fund is a venture capital investment firm based in New York, founded in 2010 by Craig Shapiro. The firm focuses on funding companies that prioritize creativity and collaborative consumption, aligning its investments with emerging trends in the creative class and sustainable business practices. Collaborative Fund targets various sectors, including climate, consumer products, industrial solutions, precision health, children's products, food, health, and financial services. As a Registered Investment Adviser, the firm aims to support innovative businesses that contribute to positive societal and environmental change.